16.14 USD
+0.01 (+0.06%)
16.14 USD
0 (0%)
Overall OFIX gets a fundamental rating of 2 out of 10. We evaluated OFIX against 188 industry peers in the Health Care Equipment & Supplies industry. OFIX has a bad profitability rating. Also its financial health evaluation is rather negative. OFIX is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
OFIX had negative earnings in the past year.
OFIX had a positive operating cash flow in the past year.
OFIX had negative earnings in 4 of the past 5 years.
In multiple years OFIX reported negative operating cash flow during the last 5 years.
1.2 Ratios
With a Return On Assets value of -14.31%, OFIX perfoms like the industry average, outperforming 56.38% of the companies in the same industry.
OFIX has a Return On Equity (-26.92%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.31% | ||
| ROE | -26.92% | ||
| ROIC | N/A |
ROA(3y)-11.59%
ROA(5y)-8.47%
ROE(3y)-18.73%
ROE(5y)-13.37%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Gross Margin value of 68.27%, OFIX is doing good in the industry, outperforming 73.40% of the companies in the same industry.
In the last couple of years the Gross Margin of OFIX has declined.
The Profit Margin and Operating Margin are not available for OFIX so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.27% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.19%
GM growth 5Y-2.65%
2. Health
2.1 Basic Checks
OFIX does not have a ROIC to compare to the WACC, probably because it is not profitable.
OFIX has more shares outstanding than it did 1 year ago.
OFIX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, OFIX has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.33, we must say that OFIX is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.33, OFIX perfoms like the industry average, outperforming 53.72% of the companies in the same industry.
OFIX has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.39, OFIX is in line with its industry, outperforming 46.81% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.33 |
ROIC/WACCN/A
WACC7.78%
2.3 Liquidity
A Current Ratio of 2.47 indicates that OFIX has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.47, OFIX is in line with its industry, outperforming 47.87% of the companies in the same industry.
A Quick Ratio of 1.38 indicates that OFIX should not have too much problems paying its short term obligations.
The Quick ratio of OFIX (1.38) is worse than 61.70% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.47 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
OFIX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10900.00%.
Measured over the past years, OFIX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -63.14% on average per year.
OFIX shows a small growth in Revenue. In the last year, the Revenue has grown by 4.31%.
Measured over the past years, OFIX shows a quite strong growth in Revenue. The Revenue has been growing by 11.69% on average per year.
EPS 1Y (TTM)-10900%
EPS 3Y-77.34%
EPS 5Y-63.14%
EPS Q2Q%-914.29%
Revenue 1Y (TTM)4.31%
Revenue growth 3Y19.84%
Revenue growth 5Y11.69%
Sales Q2Q%4.59%
3.2 Future
OFIX is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -375.84% yearly.
Based on estimates for the next years, OFIX will show a small growth in Revenue. The Revenue will grow by 4.62% on average per year.
EPS Next Y-22710.03%
EPS Next 2Y-1177.34%
EPS Next 3Y-375.84%
EPS Next 5YN/A
Revenue Next Year2.14%
Revenue Next 2Y3.88%
Revenue Next 3Y4.55%
Revenue Next 5Y4.62%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
OFIX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OFIX. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A cheap valuation may be justified as OFIX's earnings are expected to decrease with -375.84% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1177.34%
EPS Next 3Y-375.84%
5. Dividend
5.1 Amount
OFIX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
16.14
+0.01 (+0.06%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners91.86%
Inst Owner Change-1.84%
Ins Owners1.41%
Ins Owner Change4.56%
Market Cap637.37M
Revenue(TTM)818.06M
Net Income(TTM)-119.12M
Analysts85.45
Price Target23.26 (44.11%)
Short Float %4.04%
Short Ratio5.58
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.73%
Min EPS beat(2)-37.41%
Max EPS beat(2)9.96%
EPS beat(4)3
Avg EPS beat(4)47.99%
Min EPS beat(4)-37.41%
Max EPS beat(4)139.22%
EPS beat(8)7
Avg EPS beat(8)81.32%
EPS beat(12)11
Avg EPS beat(12)87.39%
EPS beat(16)13
Avg EPS beat(16)57.92%
Revenue beat(2)2
Avg Revenue beat(2)0.97%
Min Revenue beat(2)0.8%
Max Revenue beat(2)1.14%
Revenue beat(4)2
Avg Revenue beat(4)0.17%
Min Revenue beat(4)-0.65%
Max Revenue beat(4)1.14%
Revenue beat(8)4
Avg Revenue beat(8)-0.06%
Revenue beat(12)5
Avg Revenue beat(12)-1.67%
Revenue beat(16)5
Avg Revenue beat(16)-1.56%
PT rev (1m)1.11%
PT rev (3m)1.11%
EPS NQ rev (1m)-88.13%
EPS NQ rev (3m)-40.51%
EPS NY rev (1m)0%
EPS NY rev (3m)15.61%
Revenue NQ rev (1m)-0.33%
Revenue NQ rev (3m)-1.65%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.78 | ||
| P/FCF | N/A | ||
| P/OCF | 21.69 | ||
| P/B | 1.44 | ||
| P/tB | 3.71 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.08
EYN/A
EPS(NY)-1.61
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.74
OCFY4.61%
SpS20.72
BVpS11.21
TBVpS4.35
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.31% | ||
| ROE | -26.92% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.27% | ||
| FCFM | N/A |
ROA(3y)-11.59%
ROA(5y)-8.47%
ROE(3y)-18.73%
ROE(5y)-13.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.19%
GM growth 5Y-2.65%
F-Score5
Asset Turnover0.98
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 40.23% | ||
| Cap/Sales | 3.95% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.47 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 1.33 |
F-Score5
WACC7.78%
ROIC/WACCN/A
Cap/Depr(3y)86.5%
Cap/Depr(5y)81.89%
Cap/Sales(3y)6%
Cap/Sales(5y)5.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10900%
EPS 3Y-77.34%
EPS 5Y-63.14%
EPS Q2Q%-914.29%
EPS Next Y-22710.03%
EPS Next 2Y-1177.34%
EPS Next 3Y-375.84%
EPS Next 5YN/A
Revenue 1Y (TTM)4.31%
Revenue growth 3Y19.84%
Revenue growth 5Y11.69%
Sales Q2Q%4.59%
Revenue Next Year2.14%
Revenue Next 2Y3.88%
Revenue Next 3Y4.55%
Revenue Next 5Y4.62%
EBIT growth 1Y-2.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year202.59%
EBIT Next 3Y49.93%
EBIT Next 5Y38.14%
FCF growth 1Y96.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y180.14%
OCF growth 3Y11.71%
OCF growth 5Y-4.22%
ORTHOFIX MEDICAL INC / OFIX FAQ
Can you provide the ChartMill fundamental rating for ORTHOFIX MEDICAL INC?
ChartMill assigns a fundamental rating of 2 / 10 to OFIX.
Can you provide the valuation status for ORTHOFIX MEDICAL INC?
ChartMill assigns a valuation rating of 0 / 10 to ORTHOFIX MEDICAL INC (OFIX). This can be considered as Overvalued.
Can you provide the profitability details for ORTHOFIX MEDICAL INC?
ORTHOFIX MEDICAL INC (OFIX) has a profitability rating of 2 / 10.
What is the earnings growth outlook for ORTHOFIX MEDICAL INC?
The Earnings per Share (EPS) of ORTHOFIX MEDICAL INC (OFIX) is expected to decline by -22710.03% in the next year.